American Society of Gene Therapy (ASGT) Ad Hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells

Molecular Therapy

Volumn 8, Issue 2, 2003, Pages 180-187

  Kohn, Donald B ^a   Sadelain, Michel ^a   Dunbar, Cynthia ^a   Bodine, David ^a   Kiem, Hans Peter ^a   Candotti, Fabio ^a   Tisdale, John ^a   Riviére, Isabelle ^a   Blau, C Anthony ^a   Richard, Robert E ^a   Sorrentino, Brian ^a   Nolta, Jan ^a   Malech, Harry ^a   Brenner, Malcolm ^a   Cornetta, Kenneth ^a   Cavagnaro, Joy ^a   High, Katherine ^a   Glorioso, Joseph ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; CARMUSTINE; CD40 LIGAND; FLT3 LIGAND; GENE PRODUCT; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; LENTIVIRUS VECTOR; MULTIDRUG RESISTANCE PROTEIN 1; NOTCH RECEPTOR; PROTEIN BCL 2; RETROVIRUS VECTOR; TRANSFORMING GROWTH FACTOR BETA2; VIRUS PROTEIN; VIRUS VECTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADVANCED CANCER; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; B CELL LEUKEMIA; B CELL LYMPHOMA; BABOON; CAT; CELL COMPOSITION; CELL COUNT; CIRCULATION; CLINICAL OBSERVATION; CLINICAL STUDY; COMBINED IMMUNODEFICIENCY; DEATH; DISEASE ASSOCIATION; DOG; DRUG SAFETY; ENZYME DEFICIENCY; EXPERIMENTAL MODEL; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MACACA; MARKER GENE; MEDICAL SOCIETY; MOUSE; MYELOFIBROSIS; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; NEUROBLASTOMA; NONHUMAN; OSTEOSCLEROSIS; PANCYTOPENIA; PREDICTION; RABBIT; RETROVIRUS; REVIEW; SHEEP; SWINE; T CELL LEUKEMIA; THROMBOCYTOPENIA; THYMOMA; TREATMENT OUTCOME; UNITED STATES; VIRAL GENE DELIVERY SYSTEM;

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MACACA; MURINAE; ORYCTOLAGUS CUNICULUS; OVIS ARIES; PAPIO HAMADRYAS; SUS SCROFA; UNIDENTIFIED RETROVIRUS;

EID: 10744233858     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00212-0     Document Type: Review

References (16)

1. Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Morgan, R. A., Moen, R., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., et al. (1990). Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323: 570-578 (see comments).
2. D. B.Kohn, G. M.Crooks, Clinical trials of gene therapy using hematopoietic stem cells. In: E.D. Thomas, K.G. Blume, S.J. Forman (Eds.), Hematopoietic Cell Transplantation, 3rd edition, Blackwell Scientific Publications, Boston, 2003, pp. xx-xx.
3. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J. L., Bousso, P., Le Deist, F., and Fischer, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672.
4. Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J. P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., Fischer, A., Davies, E. G., Kuis, W., Leiva, L., and Cavazzana-Calvo, M. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346: 1185-1193.
5. Aiuti, A., Slavin, S., Akerm, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F., Marinello, E., Cattaneo, F., Vai, S., Servida, P., Miniero, R., Roncarolo, M. G., and Bordignon, C. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
6. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyrel. Radford, E., Villeval, J. L., Fraser, C. C., Cavazzana-Calvo, M., and Fischer, A. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348: 255-256.
7. Belmont, J. W., et al. (1988). Expression of human adenosine deaminase in murine hematopoietic cells. Mol. Cell Biol. 8: 5116-5125.
8. Li, Z., et al. (2002). Murine leukemia induced by retroviral gene marking. Science 296: 497.
9. Sadelain, M., and Riviere, I. (2002). Sturm und Drang over suicidal lymphocytes. Mol. Ther. 5: 655-657.
10. Villeval, J. L., et al. (1997). High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 90: 4369-4383.
11. Innes, K. M., et al. (1999). Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis. Exp. Hematol. 27: 75-87.
12. Li, Z., et al. (2002). Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell. Leukemia 16: 1655-1663.
13. Bunting, K. D., Galipeau, J., Topham, D., Benaim, E., and Sorrentino, B. P. (1998). Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood 92: 2269-2279.
14. Bunting, K. D., Zhou, S., Lu, T., and Sorrentino, B. P. (2000). Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 96: 902-909.
15. Licht, T., Goldenberg, S. K., Vieira, W. D., Gottesman, M. M., and Pastan, I. (2000). Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice. Gene Ther. 7: 348-358.
16. Abonour, R., Williams, D. A., Einhorn, L., Hall, K. M., Chen, J., Coffman, J., Traycoff, C. M., Bank, A., Kato, I., Ward, M., Williams, S. D., Hromas, R., Robertson, M. J., Smith, F. O., Woo, D., Mills, B., Srour, E. F., and Cornetta, K. (2000). Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat. Med. 6: 652-658 (Comment in Nat. Med. 6 (2000), 624-626).